NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Other Non-Current Liabilities (2023)

NeuroSense Therapeutics' (NRSN) quarterly Other Non-Current Liabilities came in at $1.4 million in Q4 2023.

Analysis

NeuroSense Therapeutics (NRSN) Other Non-Current Liabilities (2023) Analysis & Trends

NeuroSense Therapeutics has disclosed Other Non-Current Liabilities across 1 years of filings, most recently posting $1.4 million for Q4 2023.

  • In Q4 2023, Other Non-Current Liabilities changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2023 stood at $1.4 million (changed N/A YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
  • Other Non-Current Liabilities came in at $1.4 million for Q4 2023 at NeuroSense Therapeutics.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.4 million in Q4 2023 to a low of $1.4 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.41 Mn
API Access

NeuroSense Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NRSN&period=max&api_key=YOUR_API_KEY